Lifetime air pollution exposure and asthma in a pediatric birth cohort - 04/05/18
Doi : 10.1016/j.jaci.2017.11.062
Mary B. Rice, MD, MPH a 
, Sheryl L. Rifas-Shiman, MPH b, Augusto A. Litonjua, MD, MPH c, Matthew W. Gillman, MD, SM d, Nicole Liebman, BA a, Itai Kloog, PhD e, Heike Luttmann-Gibson, PhD f, Brent A. Coull, PhD f, Joel Schwartz, PhD f, Petros Koutrakis, PhD f, Emily Oken, MD, MPH b, f, Murray A. Mittleman, MD, DrPH f, Diane R. Gold, MD, MPH c, f
, Sheryl L. Rifas-Shiman, MPH b, Augusto A. Litonjua, MD, MPH c, Matthew W. Gillman, MD, SM d, Nicole Liebman, BA a, Itai Kloog, PhD e, Heike Luttmann-Gibson, PhD f, Brent A. Coull, PhD f, Joel Schwartz, PhD f, Petros Koutrakis, PhD f, Emily Oken, MD, MPH b, f, Murray A. Mittleman, MD, DrPH f, Diane R. Gold, MD, MPH c, f a Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Mass
b Division of Chronic Disease Research Across the Lifecourse, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass
c Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass
d Environmental Influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health, Bethesda, Md
e Department of Geography and Environmental Development, Ben-Gurion University of the Negev, Beer Sheva, Israel
f Harvard T.H. Chan School of Public Health, Boston, Mass
| Supported by the US National Institutes of Health (K23ES026204, P30ES000002, P01ES009825, K24HD069408, R37HD034568 R01AI102960, and UG3OD023286), the US Environmental Protection Agency (EPA; RD-835872), the American Thoracic Society Foundation, and the American Lung Association. This publication's contents are solely the responsibility of the grantee and do not necessarily represent the official views of the EPA. Further, the EPA does not endorse the purchase of any commercial products or services mentioned in the publication. The views expressed in this article do not necessarily represent the views of the US Government, the Department of Health and Human Services, or the National Institutes of Health. |
|
| Disclosure of potential conflict of interest: M. B. Rice's institution has received grant funding from the National Institutes of Health (NIH), the American Thoracic Society, and the American Lung Association, and she has received travel funding and support for lecturing at various academic medical centers. A. A. Litonjua has received consultancy fees from AstraZeneca and receives royalties from UpToDate, and his institution has received NIH grant funding. B. A. Coull's institution has received grant funding from the NIH and the US Environmental Protection Agency (EPA). P. Koutrakis' institution has received a grant from the US EPA (RD-835872). E. Oken's institution has received NIH grant funding. M. A. Mittleman's institution has received grant funding from the NIH and US EPA. D. R. Gold's institution has received grant funding from the NIH and US EPA. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 5
P. 1932 - mai 2018 Retour au numéro
Article précédent
- Group 2 innate lymphoid cells promote airway hyperresponsiveness through production of VEGFA
- Xiaofei Shen, Muhammad Asghar Pasha, Kelsi Hidde, Adil Khan, Mingwei Liang, Wenxian Guan, Yitao Ding, Angela Haczku, Qi Yang
- SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis
- Mizuho Nagao, Shinichiro Inagaki, Toshiki Kawano, Yoshinori Azuma, Noriko Nomura, Yasuhiko Noguchi, Shoichiro Ohta, Atsushi Kawaguchi, Hiroshi Odajima, Yukihiro Ohya, Takao Fujisawa, Kenji Izuhara
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?